| Stem Cell Research and Therapy |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Anaphylaxis |
0 |
0.86 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.86 |
| Viral Infection |
0 |
0.98 |
| Toxicology |
0 |
0.42 |
| Cancer |
0 |
0.38 |
| Transplantation |
0 |
0.99 |
| Genomic Medicine |
0 |
0.34 |
| Antiviral Agents |
0 |
0.28 |
| Child |
0 |
0.28 |
| Viral Load |
0 |
0.28 |
| Urinary Tract Infection |
0 |
0.21 |
| Hospital |
0 |
0.19 |
| Texas |
0 |
0.19 |
| Wound Management |
0 |
0.18 |
| Graft Versus Host Disease |
0 |
0.13 |
| Infective Cystitis |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Multiple Sclerosis |
0 |
0.1 |
| Adenovirus |
0 |
0.09 |
| Bladder |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Cytokines |
0 |
0.09 |
| Cytomegalovirus |
0 |
0.09 |
| Epstein-Barr Virus |
0 |
0.09 |
| Gene Therapy |
0 |
0.09 |
| Graft |
0 |
0.09 |
| Heart |
0 |
0.09 |
| Herpes Viruses |
0 |
0.09 |
| Injury |
0 |
0.09 |
| JC Virus |
0 |
0.09 |
| Kidney |
0 |
0.09 |
| Lung |
0 |
0.09 |
| Myelosuppression |
0 |
0.09 |
| Refractory |
0 |
0.09 |
| Washington |
0 |
0.09 |